Retatrutide: Why Everyone’s Talking About It, and Why We Aren’t Prescribing It (Yet)

Retatrutide is getting a lot of attention in the metabolic and weight-management world—and we completely understand why patients are curious. Early trial results look impressive, and many people are wondering if it’s the next step after semaglutide or tirzepatide. We’ve been watching the research closely, and we’re excited about the possibilities. But right now, Flow Wellness is not prescribing retatrutide, and here’s the straightforward reason why.

What Is Retatrutide?

Retatrutide is an investigational medication currently in clinical trials. It’s unique because it targets three receptors involved in metabolism:

• GLP-1

• GIP

• Glucagon

This triple-agonist activity may lead to faster and more powerful fat-loss and metabolic improvements than current medications. In early Phase 2 data, patients saw significant weight reduction and major improvements in metabolic health markers. Truly exciting science.

So Why Aren’t We Prescribing It?

1. It Isn’t FDA-Approved

Retatrutide is still in Phase 3 clinical trials. That means:

• It has not been reviewed or approved for safety or effectiveness

• There are no established dosing guidelines

• It is not legally available for general prescribing

2. It Cannot Be Safely or Legally Compounded

Even though many peptides can be made by compounding pharmacies, retatrutide cannot. Because it’s still investigational and under patent protection:

• Pharmacies in the U.S. cannot legally produce it

• Any clinic offering it is using a product with unknown purity, potency, or sterility (yikes!)

• There is no above-board, reliable way to obtain retatrutide in the United States today outside of an official clinical trial

We will never risk your safety by using an unverified source.

3. Safety Questions Still Need Real-World Answers

Early research shows increased GI side effects and possible lean-mass loss at higher doses. We want strong evidence that benefits outweigh risks before prescribing it broadly.

What We’re Doing Instead

While we wait for stronger safety data and legal availability, we offer proven, customizable metabolic tools with excellent patient outcomes:

• Semaglutide

• Tirzepatide

• Brand name GLP-1  medication like Zepbound and Wegovy

• GLP-1 microdosing protocols

• Supportive peptide therapy ( Growth Hormone Peptides Explained and more)

• Comprehensive metabolic and hormone balance optimization

These options let us tailor treatment safely and effectively—without cutting corners.

Looking Ahead

If retatrutide becomes:

• FDA-approved,

• supported by robust safety data,

• and available from legitimate manufacturers,

we will evaluate it carefully and may offer it when the time is right. We love innovation, but we will never compromise patient safety for hype or speed.

Our Promise

We will always:

• Prioritize your safety

• Use only legitimate, verifiable medications

• Stay on the leading edge of research without gambling with patient trust

We’re here to support you, answer questions honestly, and help you choose the safest and most effective treatment plan for your goals. You’ll be the first to know if/when we are able to start supplying our patient with this next generation of GLP-1 medication!

Curious About Options or Want Guidance?

Reach out. We’re happy to talk through what’s available now and help you decide what’s best for your body and your health journey.

Contact your provider through the patient portal